Purpose: The aim of this study is to compare the functional outcomes and osteoarthritis (OA) progression after anterior cruciate ligament (ACL) reconstruction with either hamstring autografts or allografts in people over 50. Methods: The clinical records of two consecutive cohorts of 61 cases in total over 50 years of age, undergoing ACL reconstruction, were included. The first cohort consisted of 29 allografts; the second cohort consisted of 32 autologous hamstring tendon grafts. The cases were evaluated pre- (T0) and post-operatively at six months (T1), 12 months (T2) and 24 months (T3). Clinical examination included the Lachman test, pivot shift test and objective (Objective IKDC [The International Knee Documentation Committee] score) and subjective clinical scores (Subjective IKDC score, Lysholm score and Tegner activity score). The degree of OA was evaluated using the Kellgren-Lawrence system at the time of the final follow-up, compared to the pre-operative condition. Results: No pre-operative difference was found between the two groups (p > 0.05). No statistical difference was noted between the two groups at each follow-up (p > 0.05). At the final follow-up, both the groups significantly improved statistically in all the clinical and functional scores (p < 0.05). In both groups, one graft re-rupture was noted. No progression of OA was noted in both groups at final follow-up (p > 0.05). Conclusion: The graft choice does not influence the outcomes two years after ACL reconstruction in people over 50; thus, both treatments help in regaining knee stability with no signs of OA progression. Registration: Researchregistry7539–www.researchregistry.com.
Purpose: This study aimed to evaluate the impact of Robotic-Assisted Total Hip Arthroplasty (RATHA) versus Conventional Total Hip Arthroplasty (CTHA) on perioperative blood loss, blood transfusion requirements, and early clinical outcomes. Methods: A prospective cohort study was conducted at a high-volume tertiary care center from January 2021 to January 2023. A total of 200 patients undergoing primary THA were equally divided into RATHA (using the MAKO SmartRobotics system) and CTHA cohorts. Propensity score matching adjusted for demographics and baseline characteristics, resulting in 172 matched patients. Primary outcomes included changes in perioperative hemoglobin, estimated blood loss (EBL), and transfusion rates. Secondary outcomes assessed were operative time, length of stay, and transfusion-related adverse events. Results: The RATHA group demonstrated significantly lower post-operative hemoglobin drops (2.49 ± 0.6 g/dL vs. 3.38 ± 1.0 g/dL; p < 0.001), reduced EBL on post-operative day 3 (1125.52 ± 361.2 mL vs. 1611.12 ± 501.4 mL; p < 0.0001), and lower transfusion rates (7.96% vs. 20.4%; p = 0.0175) compared to the CTHA group. Operative time was significantly shorter in the RATHA group (68.01 ± 8.7 minutes vs. 77.1 ± 10.5 minutes; p < 0.0001). All robotic cohort patients were discharged within 3 days, whereas 14% of CTHA patients required extended hospitalization. Conclusion: This study demonstrates that robotic-assisted total hip arthroplasty (RATHA) significantly reduces perioperative blood loss, hemoglobin drop, and blood transfusion rates compared to conventional total hip arthroplasty (CTHA). The observed decrease in operative time and hospital stay in the RATHA group further suggests that robotic assistance may enhance procedural efficiency and support faster patient recovery.